Table 2 Comparison of TB score and incidence of clinical symptoms between two groups of patients.
From: Impact of hyperglycemia on tuberculosis treatment outcomes: a cohort study
Variables | Baseline | P | 2-month | P | ||
|---|---|---|---|---|---|---|
Non-hyperglycemia (N = 525) | Hyperglycemia (N = 266) | Non-hyperglycemia (N = 509) | Hyperglycemia (N = 242) | |||
TB score ≥ 4 | 65 (12.4) | 54 (20.3) | 0.004 | 11 (3.1) | 3 (1.7) | 0.410 |
Cough | 331 (63.0) | 190 (71.4) | 0.019 | 127 (25.0) | 88 (36.4) | 0.001 |
Sputum production | 245 (46.7) | 138 (51.9) | 0.166 | 76 (14.9) | 56 (23.1) | 0.006 |
Hemoptysis | 46 (8.8) | 33 (12.4) | 0.106 | 6 (1.2) | 5 (2.1) | 0.345 |
Fever | 123 (23.4) | 63 (23.7) | 0.936 | 8 (1.6) | 6 (2.5) | 0.397 |
Chest pain | 80 (15.2) | 37 (13.9) | 0.619 | 40 (7.9) | 23 (9.5) | 0.462 |
Fatigue | 114 (21.7) | 85 (32.0) | 0.002 | 123 (24.2) | 63 (25.9) | 0.611 |
Night sweats | 79 (15.0) | 56 (21.1) | 0.034 | 39 (7.7) | 32 (13.2) | 0.015 |
Loss of appetite | 98 (18.7) | 65 (24.4) | 0.058 | 57 (11.1) | 28 (11.3) | 0.934 |
